期刊文献+

乳腺癌低负荷前哨淋巴结阳性对非前哨淋巴结转移的预测分析 被引量:4

Status of the non-sentinel lymph node metastasis in breast cancer patients with small number of positive sentinel lymph node
原文传递
导出
摘要 目的探讨前哨淋巴结(sentinel lymphnode,SLN)阳性≤2个乳腺癌非前哨淋巴结(non—sen—tinellymphnode.NSLN)状态及其影响因素。方法回顾性分析88例SLN阳性≤2个的乳腺癌病例资料,分析NSLN状态相关影响因素。结果88例病例资料纳入分析,8例NSLN出现转移(9.09%),方差分析显示肿瘤分期(P-0.046)、组织学分级(P=0.014)、ER状态(P=0.009)在NSLN阳性和阴性2组中分布存在差异,Logistic多因素分析显示组织学分级是NSLN状态的独立影响因素(P=0.016,OR=1.150,95%C1=0.598—7.740)。SLN微转移18例(20.45%),宏转移70例(79.54%),SLN假阴性率10.23%。中位随访时间11个月,无复发、转移、死亡病例。结论低负荷SLN阳性的乳腺癌患者,NSLN转移率较低,NSLN转移受肿瘤分期、组织学分级、ER表达情况等因素影响。 Objective To explore the risk factors and metastasis of non-sentinel lymph node (NSLN) in breast cancer patients with sentinel lymph node metastasis ≤ 2. Methods 88 cases of breast cancer with sentinel lymph node metastasis≤2 were retrospectively analyzed. Factors influencing the status of NSLN were studied. Results 8 cases (9.09%) had NSLN metastasis. Variance analysis showed that tumor stage(P=0.014), histological grade(P=0.014) and ER statuts(P=-0.009) were correlated with NSLN metastasis. Logistic analysis showed that only histological grade was the independent predictor for NSLN metastasis (P=0.016,OR=1.150,95% CI=0.598- 7.740).18 eases had micro-metastasis of sentinel lymph node and 70 cases had macro-metastasis of sentinel lymph node. The ratio of false negative SLN was 10.23%. The mean follow-up time was 11 months. There was no case of recurrence, metastasis or death. Conclusions The metastasis rate of NSLN is relatively low in breast cancer patients with small number of positive SLNs. NSLN metastasis is related to tumor stage, histological grade, and ER expression.
出处 《中华内分泌外科杂志》 CAS 2016年第2期144-147,151,共5页 Chinese Journal of Endocrine Surgery
关键词 乳腺肿瘤 前哨淋巴结 淋巴转移 Breast cancer Sentinel lymph node Lymphatic metastasis
  • 相关文献

参考文献14

  • 1Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC ran- domised trial comparing sentinel node biopsy with standard axil- lary treatment in the management of patients with early breast cancer[J]. Breast Cancer Res Treat,2006,95 (3):279-293. DOI: 10.1007/s 10549 -005 -9025 -7.
  • 2Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node re- section compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer:, overall survival findings from the NSABP B-32 randomised phase 3 trial [J]. Lancet Oncol,2010,11 (10):927-933. DOI:10.1016/S1470-2045 (10)70207-2.
  • 3Ashikaga T, Krag DN, Stephanie R. et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection[J]. J Surg Oncol,2010,102 (2):111-118. DOI: l O.l OO2/jso.21535.
  • 4Meretoja TJ, Leidenius MH, Heikkila PS, et al. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer[J]. J Natl Cancer Inst,2012,104 (24):1888-1896. DOI: 10.1093/jnci/djs455.
  • 5Delpech Y, Brieou A, Lousquy R, et al. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study[J]. Ann Surg Oncol,2013,20 (8):2556-2561. DOI:10.1245/ s 10434-O13-2917-6.
  • 6Giuliano AE, Morrow M, Duggal S, et al. Should ACOSOG Z001 1 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer[J]. Clin Exp Metastasis,2012,29 (7):687-692. DOI:10.1007/s 10585-012-9515-z.
  • 7Friedman D, Gipponi M, Murelli F, et al. Predictive factors ofnon-sentinel lymph node involvement in patients with invasive breast cancer andsentinel node micrometastases [J]. Anticancer Res,2013,33 ( 10 ) :4509-4514.
  • 8Tausch C, Taucher S, Dubsky P, et al. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto tri- als of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)[J]. Ann Surg Oncol,2012,19(6):1808-1817. DOI:10.1245/ s10434-011-2189-y.
  • 9曹迎明,刘淼,周波,潘璐,王殊,杨德起.MSKCC和SOC模型预测中国乳腺癌患者非前哨淋巴结转移的验证比较研究[J].中国肿瘤临床,2014,41(8):508-512. 被引量:12
  • 10杨奔,郑刚,左文述,杨莉,王永胜,郑美珠,刘岩松,于志勇.乳腺癌前哨淋巴结活检假阴性率的单中心多因素分析[J].中华肿瘤杂志,2013,35(5):389-393. 被引量:28

二级参考文献35

  • 1张建国,仲雷,李传乐,郭宝良,杨学伟.前哨淋巴结活检术检测乳腺癌腋窝淋巴结转移的效果评价[J].中华肿瘤杂志,2007,29(3):235-236. 被引量:4
  • 2Takei H, Kurosumi M, Yoshida T, et al. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Breast Cancer, 2010, 17:9-16.
  • 3Taras AR, Hendrickson NA, Lowe KA, et al. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes. Am J Surg, 2010, 199:625-625.
  • 4Pesek S, Ashikaga T, Krag LE, et al. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta- analysis. World J Surg, 2012, 36:2239-2251.
  • 5Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer:results of the ALMANAC validation phase. Breast Cancer Res Treat, 2006, 99:203-208.
  • 6Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer:a muhieenter validation study. N Engl J Med, 1998, 339 : 941-946.
  • 7Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oneology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oneol, 2007, 25 : 118-145.
  • 8Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta analysis. Cancer, 2006, 106:4-16.
  • 9Javan H, Gholami H, Assadi M, et al. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion : systematic review and meta- analysis of the literature. Eur J Surg Oncol, 2012, 38:95-109.
  • 10Andersson Y, de Boniface J, Jonsson PE , et al. Axillary recttrrence rate 5 years after negative sentinel node biopsy for breast cancer. Br J Surg, 2012, 99: 226-231.

共引文献38

同被引文献33

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部